Login  |  Register

Statistics

  • Active Listings: 14638
  • Pending Listings: 0
  • Todays Listings: 0
  • Total Categories: 44
  • Sub Categories: 874

Pazopanib: A Formulary Dossier - slideshare.net

Pazopanib (VotrientTM) is a multi-target tyrosine kinase inhibitor approved by the FDA for the treatment of renal cell carcinoma. Renal cell carcinoma is the most ...

Alexa Traffic


Listing Links